sulfisoxazole has been researched along with methylprednisolone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brockhurst, RJ; McMeel, JW; Okamura, ID; Regan, CD; Schepens, CL | 1 |
| Chrai, SS; Mikkelson, TJ; Robinson, JR | 2 |
| Martínez Muñóz, J | 1 |
| Shealy, CN | 1 |
| Brown, A; Elder, EM; Luft, BJ; Naot, Y; Remington, JS; Shonnard, J | 1 |
13 other study(ies) available for sulfisoxazole and methylprednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Scleral buckling procedures. 8. Preoperative complications.
Topics: Acetazolamide; Adrenocorticotropic Hormone; Anesthetics, Local; Choroid; Conjunctivitis; Dacryocystitis; Glaucoma; Humans; Meprobamate; Methylprednisolone; Mydriatics; Phenylephrine; Prednisolone; Preoperative Care; Retinal Detachment; Sulfisoxazole; Tetracaine; Uveitis | 1965 |
Altered bioavailability of drugs in the eye due to drug-protein interaction.
Topics: Animals; Aqueous Humor; Biopharmaceutics; Cornea; Dialysis; Drug Interactions; Eye Proteins; Kinetics; Male; Methylprednisolone; Mitosis; Naphthalenes; Pharmaceutical Preparations; Pilocarpine; Protein Binding; Rabbits; Serum Albumin; Solutions; Sulfisoxazole; Sulfonamides; Tears; Time Factors; Tritium | 1973 |
Competitive inhibition of drug-protein interaction in eye fluids and tissues.
Topics: Animals; Binding, Competitive; Biopharmaceutics; Cetylpyridinium; Cornea; Dialysis; Dose-Response Relationship, Drug; Drug Antagonism; Ethylenediamines; Eye; Eye Proteins; In Vitro Techniques; Male; Methylprednisolone; Miotics; Naphthalenes; Pharmaceutical Preparations; Pilocarpine; Protein Binding; Rabbits; Serum Albumin; Sulfisoxazole; Surface-Active Agents; Time Factors | 1973 |
[Waterhouse-Friderichsen syndrome with favorable response to medical treatment].
Topics: Adolescent; Drug Evaluation; Humans; Injections, Intravenous; Male; Methylprednisolone; Penicillin G; Sulfisoxazole; Waterhouse-Friderichsen Syndrome | 1970 |
Dangers of spinal injections without proper diagnosis.
Topics: Anesthesia, Inhalation; Cerebrospinal Fluid Proteins; Chloramphenicol; Diagnosis, Differential; Diatrizoate; Halothane; Humans; Injections, Spinal; Intervertebral Disc; Laminectomy; Male; Methylprednisolone; Middle Aged; Myelography; Neurosurgery; Spinal Cord Diseases; Sulfisoxazole | 1966 |
IgM and IgG antibody response in two immunosuppressed patients with Legionnaires' disease. Evidence of reactivation of latent infection.
Topics: Adult; Antibodies, Anti-Idiotypic; Antibodies, Bacterial; Erythromycin; Heart Transplantation; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppression Therapy; Legionnaires' Disease; Male; Methylprednisolone; Middle Aged; Sulfisoxazole | 1982 |